Unlocking the Future of the Canine Arthritis Treatment Market: Growth Rate, Key Trends, and Opportunities for 2025-2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What fueled the previous growth in the canine arthritis treatment market?
The canine arthritis treatment market has grown strongly in recent years. It will expand from $2.35 billion in 2024 to $2.48 billion in 2025, at a compound annual growth rate (CAGR) of 5.6%. Growth is due to the aging pet population, heightened awareness among pet owners, focus on preventive care, higher disposable income, and growing expenditure on veterinary care.
What will be the canine arthritis treatment market size in the future?
The canine arthritis treatment market is forecasted to grow to $3.06 billion by 2029, at a CAGR of 5.4%. The growth is attributed to a rise in pet insurance coverage, increasing arthritis cases, higher pet ownership, demand for minimally invasive procedures, and the growing prevalence of arthritis in dogs. Trends include innovative treatments, advancements in veterinary medicine, demand for advanced therapies, the integration of technology, and emerging innovative technologies.
Get your canine arthritis treatment market report here!
https://www.thebusinessresearchcompany.com/report/canine-arthritis-treatment-global-market-report
What main drivers are fueling expansion in the canine arthritis treatment market?
The rising rate of pet ownership is expected to boost the canine arthritis treatment market. As more people own pets, the demand for arthritis treatments for dogs is increasing. The American Pet Products Association reported that 66% of U.S. households owned pets in 2022, supporting the growth of this market.
What key areas define the segmentation of the global canine arthritis treatment market?
The canine arthritis treatment market covered in this report is segmented –
1) By Treatment Type: Drugs, Supplements, Surgical Procedures, Other Treatment Types
2) By Route Of Administration: Oral, Parenteral, Other Routes Of Administrations
3) By Arthritis Type: Osteoarthritis, Rheumatoid Arthritis, Osteochondrosis, Traumatic Arthritis
4) By Distribution Channels: Veterinary Clinics And Hospitals, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Drugs: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Disease-Modifying Osteoarthritis Drugs (DMOADs), Corticosteroids, Analgesics And Pain Relievers
2) By Supplements: Glucosamine And Chondroitin Supplements, Omega-3 Fatty Acids And Fish Oil, Hyaluronic Acid Supplements, MSM (Methylsulfonylmethane) Supplements, Collagen-Based Supplements
3) By Surgical Procedures: Joint Replacement Surgery, Arthroscopy, Osteotomy, Synovectomy
4) By Other Treatment Types: Physical Therapy, Stem Cell Therapy, Platelet-Rich Plasma (PRP) Therapy, Cold Laser Therapy (Low-Level Laser Therapy), Acupuncture
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16007&type=smp
Who are the dominant players expanding their reach in the canine arthritis treatment market?
Major companies operating in the canine arthritis treatment market are Merck & Co. Inc., Bayer AG, Eli Lilly and Company, Zoetis Inc., Boehringer Ingelheim Animal Health, Elanco Animal Health Incorporated, Royal Canin SAS, Virbac Group, Ceva Sante Animale S.A., Hill’s Pet Nutrition Inc., Vetoquinol SA, Norbrook Laboratories Limited, American Regent Inc., Thorne Healthtech Inc., VetStem Inc., Eltech K-Laser s.r.l., Liquid Health Inc, Nutri-Vet LLC, OrthoPets LLC, Rejuvenate Bio Inc.
How are evolving market trends shaping canine arthritis treatment Strategies?
In the canine arthritis treatment market, companies are developing innovative solutions like bedinvetmab injections to improve joint health in dogs. For instance, in May 2023, Zoetis Inc., a US-based animal health company, received FDA approval for Librela, a bedinvetmab injection designed for managing osteoarthritis pain in dogs. This first-ever monoclonal antibody treatment for canine osteoarthritis offers a monthly subcutaneous injection to target and neutralize the pain-causing nerve growth factor (NGF), providing long-term pain relief.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16007
Which regions are emerging as leaders in the canine arthritis treatment market?
North America was the largest region in the canine arthritis treatment market in 2024. Asia-Pacifica is expected to be the fastest-growing region in the forecast period. The regions covered in the canine arthritis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Gastrointestinal Bleeding Treatment Devices Global Market Report 2024
Psoriatic Arthritis Treatment Global Market Report 2024
Point-of-Use Water Treatment Systems Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
